Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-20-019931

Director bought 400,000 shares at $19.00 ($7,600,000)

  • Director acquired 3,779,875 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Lettmann Jason · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2020-07-21 Conversion : show line 1 in the form +88,704 107,220 D
2020-07-21 Conversion : show line 2 in the form +1,831,027 2,268,087 I
2020-07-21 Conversion : show line 3 in the form +249,632 309,222 I
2020-07-21 Purchase : show line 4 in the form +378,000 $19.00 $7,182,000 378,000 I
2020-07-21 Conversion : show line 5 in the form +1,498,984 2,023,469 I
2020-07-21 Purchase : show line 6 in the form +22,000 $19.00 $418,000 22,000 I
2020-07-21 Conversion : show line 7 in the form +111,528 120,212 I
Open-market purchases · 400,000 sh · avg $19.00 · $7,600,000

Table II: Derivative

14 lines
Date Transaction Shares Owned after D/I
2020-07-21 Conversion : show line 8 in the form Series A Convertible Preferred Stock −78,175 0 D
2020-07-21 Conversion : show line 9 in the form Series A Convertible Preferred Stock −1,633,743 0 I
2020-07-21 Conversion : show line 10 in the form Series A Convertible Preferred Stock −222,752 0 I
2020-07-21 Conversion : show line 11 in the form Series A Convertible Preferred Stock −683,523 0 I
2020-07-21 Conversion : show line 12 in the form Series A Convertible Preferred Stock −39,758 0 I
2020-07-21 Conversion : show line 13 in the form Series B Convertible Preferred Stock −59,998 0 I
2020-07-21 Conversion : show line 14 in the form Series B Convertible Preferred Stock −8,175 0 I
2020-07-21 Conversion : show line 15 in the form Series B Convertible Preferred Stock −150,801 0 I
Loading xslF345X03/doc4.xml…